Clinical Trial Update: Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab [NA]

View source ↗

Summary

Clinical trial update on the effect of ozone on airway inflammation in patients with allergic asthma treated with omalizumab; the study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Asthma, Allergy | NA | Status: TERMINATED